ImmuCell FY 2025 Results Highlight Growth in Bovine Health Sector
ImmuCell (ICCC) reported its unaudited financial results for the full year 2025, reflecting a period of manufacturing expansion and sustained demand for its FirstDefense product line. Concurrently, major investor Pinetree Capital Ltd. announced its own audited results and a new director appointment, signaling continued strategic oversight of its animal health portfolio.